Dries Reynders

2.4k total citations · 1 hit paper
22 papers, 1.2k citations indexed

About

Dries Reynders is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Dries Reynders has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Dries Reynders's work include Cancer Immunotherapy and Biomarkers (6 papers), Prostate Cancer Treatment and Research (5 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Dries Reynders is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Prostate Cancer Treatment and Research (5 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Dries Reynders collaborates with scholars based in Belgium, United States and Denmark. Dries Reynders's co-authors include Els Goetghebeur, Piet Ost, Karel Decaestecker, Valérie Fonteyne, Bieke Lambert, Steven Joniau, Friedl Vanhaverbeke, Louke Delrue, Kathia De Man and Ignace Billiet and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Clinical Chemistry.

In The Last Decade

Dries Reynders

18 papers receiving 1.2k citations

Hit Papers

Surveillance or Metastasis-Directed Therapy for Oligometa... 2017 2026 2020 2023 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
    2017 831 citations Piet Ost, Dries Reynders et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dries Reynders Belgium 11 854 410 285 207 188 22 1.2k
Aurélie De Bruycker Belgium 9 1.0k 1.2× 494 1.2× 197 0.7× 154 0.7× 217 1.2× 20 1.2k
Boris Bahoric Canada 16 454 0.5× 154 0.4× 164 0.6× 153 0.7× 131 0.7× 75 770
Wolfgang Loidl Austria 23 1.5k 1.8× 768 1.9× 448 1.6× 338 1.6× 80 0.4× 71 1.9k
Béatrice Fournier Belgium 9 533 0.6× 237 0.6× 387 1.4× 221 1.1× 124 0.7× 22 913
Maurits Wondergem Netherlands 16 729 0.9× 576 1.4× 175 0.6× 202 1.0× 126 0.7× 63 1.1k
Qinfu Feng China 20 849 1.0× 268 0.7× 452 1.6× 377 1.8× 110 0.6× 123 1.3k
Rie Nakahara Japan 19 752 0.9× 269 0.7× 251 0.9× 307 1.5× 95 0.5× 58 1.2k
Masaru Wakatsuki Japan 19 438 0.5× 195 0.5× 225 0.8× 393 1.9× 286 1.5× 93 1.2k
Renuka Malik United States 15 694 0.8× 284 0.7× 234 0.8× 253 1.2× 322 1.7× 60 1.0k
Gordana Jovic United Kingdom 14 544 0.6× 134 0.3× 439 1.5× 303 1.5× 227 1.2× 30 1.1k

Countries citing papers authored by Dries Reynders

Since Specialization
Citations

This map shows the geographic impact of Dries Reynders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dries Reynders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dries Reynders more than expected).

Fields of papers citing papers by Dries Reynders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dries Reynders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dries Reynders. The network helps show where Dries Reynders may publish in the future.

Co-authorship network of co-authors of Dries Reynders

This figure shows the co-authorship network connecting the top 25 collaborators of Dries Reynders. A scholar is included among the top collaborators of Dries Reynders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dries Reynders. Dries Reynders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vandamme, Timon, Geert Roeyen, Dries Reynders, et al.. (2025). Stereotactic body radiation therapy for inoperable non-metastasized pancreatic adenocarcinoma: a randomised phase II study (TORPEDO).. BMC Cancer. 25(1). 1671–1671.
2.
Damme, Inge Van, Chiara Trevisan, Dominik Stelzle, et al.. (2025). Evaluation of a rapid lateral flow assay for the detection of taeniosis and cysticercosis at district hospital level in Tanzania: A prospective multicentre diagnostic accuracy study. PLoS neglected tropical diseases. 19(3). e0012310–e0012310.
3.
Sundahl, Nora, Vibeke Krüse, Sylvie Rottey, et al.. (2023). Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. JAMA Oncology. 9(9). 1205–1205. 54 indexed citations
4.
Ceelen, Wim, Leen Van de Sande, Martin Graversen, et al.. (2022). Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases. EBioMedicine. 82. 104151–104151. 27 indexed citations
5.
Damme, Inge Van, Chiara Trevisan, Veronika Schmidt, et al.. (2021). Evaluation of an Antibody Detecting Point of Care Test for Diagnosis of Taenia solium Cysticercosis in a Zambian Rural Community: A Prospective Diagnostic Accuracy Study. Diagnostics. 11(11). 2121–2121. 11 indexed citations
6.
Trevisan, Chiara, Inge Van Damme, Veronika Schmidt, et al.. (2021). Challenges Encountered When Evaluating an Antibody-Detecting Point-of-Care Test for Taeniosis in an Endemic Community in Zambia: A Prospective Diagnostic Accuracy Study. Diagnostics. 11(11). 2039–2039. 2 indexed citations
7.
8.
Sande, Leen Van de, Martin Graversen, An Vermeulen, et al.. (2021). Intraperitoneal aerosolization of albumin-bound paclitaxel nanoparticles (Abraxane®) for peritoneal metastasis: a phase I first-in-human study. European Journal of Surgical Oncology. 47(2). e29–e29. 2 indexed citations
9.
Sundahl, Nora, Sylvie Rottey, Vibeke Krüse, et al.. (2021). OC-0625 Immuno-radiotherapy in solid tumors: preliminary results of the randomized phase 2 CHEERS trial. Radiotherapy and Oncology. 161. S490–S491. 5 indexed citations
10.
Ost, Piet, Shankar Siva, Dries Reynders, et al.. (2021). Metastasis-directed therapy for oligorecurrent prostate cancer: A pooled analysis of prospective trials. European Urology. 79. S1175–S1175. 1 indexed citations
11.
Ost, Piet, Dries Reynders, Karel Decaestecker, et al.. (2020). Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial.. Journal of Clinical Oncology. 38(6_suppl). 10–10. 91 indexed citations
12.
Ost, Piet, Dries Reynders, Nicolaas Lumen, et al.. (2020). OC-0370: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer (STOMP). Radiotherapy and Oncology. 152. S200–S201. 1 indexed citations
13.
Kataoka, Kozo, Manabu Shiozawa, Dries Reynders, et al.. (2019). Prognostic significance of number versus location of positive mesenteric nodes in stage iii colon cancer. European Journal of Surgical Oncology. 45(10). 1862–1869. 10 indexed citations
14.
Reynders, Dries, et al.. (2018). Adenocarcinoma of the Rectum in a 27-year-old Patient with Usher Syndrome : Is there a Genetic Correlation?. Acta gastro-enterologica belgica. 80(1). 77–78. 1 indexed citations
15.
Sundahl, Nora, Katrien De Wolf, Sylvie Rottey, et al.. (2017). A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response. Journal of Translational Medicine. 15(1). 150–150. 26 indexed citations
16.
Ost, Piet, Dries Reynders, Karel Decaestecker, et al.. (2017). Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial. Journal of Clinical Oncology. 36(5). 446–453. 831 indexed citations breakdown →
17.
Sundahl, Nora, Katrien De Wolf, Vibeke Krüse, et al.. (2017). Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma. International Journal of Radiation Oncology*Biology*Physics. 100(4). 906–915. 26 indexed citations
18.
Thienpont, Linda M., Katleen Van Uytfanghe, Dries Reynders, et al.. (2017). Harmonization of Serum Thyroid-Stimulating Hormone Measurements Paves the Way for the Adoption of a More Uniform Reference Interval. Clinical Chemistry. 63(7). 1248–1260. 64 indexed citations
19.
Uytfanghe, Katleen Van, Dries Reynders, Barnali Das, et al.. (2017). Standardization of Free Thyroxine Measurements Allows the Adoption of a More Uniform Reference Interval. Clinical Chemistry. 63(10). 1642–1652. 32 indexed citations
20.
Reynders, Dries, et al.. (2003). Handelen van de bedrijfsarts bij werknemers met astma of COPD. Geautoriseerde richtlijn, augustus 2003. Tijdschrift voor bedrijfs- en verzekeringsgeneeskunde. 11(12). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurélie De Bruycker Breakdown of academic impact, for papers by Boris Bahoric Breakdown of academic impact, for papers by Wolfgang Loidl Breakdown of academic impact, for papers by Béatrice Fournier Breakdown of academic impact, for papers by Maurits Wondergem Breakdown of academic impact, for papers by Qinfu Feng Breakdown of academic impact, for papers by Rie Nakahara Breakdown of academic impact, for papers by Masaru Wakatsuki Breakdown of academic impact, for papers by Renuka Malik Breakdown of academic impact, for papers by Gordana Jovic
Rankless by CCL
2026